ABSI
Price
$2.64
Change
-$0.06 (-2.22%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
355.89M
89 days until earnings call
ELDN
Price
$3.13
Change
-$0.02 (-0.63%)
Updated
May 22, 12:32 PM (EDT)
Capitalization
183.24M
77 days until earnings call
Interact to see
Advertisement

ABSI vs ELDN

Header iconABSI vs ELDN Comparison
Open Charts ABSI vs ELDNBanner chart's image
Absci
Price$2.64
Change-$0.06 (-2.22%)
Volume$112.69K
Capitalization355.89M
Eledon Pharmaceuticals
Price$3.13
Change-$0.02 (-0.63%)
Volume$300
Capitalization183.24M
ABSI vs ELDN Comparison Chart
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. ELDN commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and ELDN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (ABSI: $2.70 vs. ELDN: $3.15)
Brand notoriety: ABSI and ELDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 86% vs. ELDN: 85%
Market capitalization -- ABSI: $355.89M vs. ELDN: $183.24M
ABSI [@Biotechnology] is valued at $355.89M. ELDN’s [@Biotechnology] market capitalization is $183.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileELDN’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • ELDN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABSI and ELDN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 5 TA indicator(s) are bullish while ELDN’s TA Score has 4 bullish TA indicator(s).

  • ABSI’s TA Score: 5 bullish, 4 bearish.
  • ELDN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ABSI is a better buy in the short-term than ELDN.

Price Growth

ABSI (@Biotechnology) experienced а -7.22% price change this week, while ELDN (@Biotechnology) price change was +11.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

ABSI is expected to report earnings on Aug 19, 2025.

ELDN is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($356M) has a higher market cap than ELDN($183M). ABSI YTD gains are higher at: 3.053 vs. ELDN (-23.544). ELDN has higher annual earnings (EBITDA): -55.85M vs. ABSI (-83.27M). ABSI has more cash in the bank: 127M vs. ELDN (78.2M). ELDN has less debt than ABSI: ELDN (501K) vs ABSI (12M). ABSI has higher revenues than ELDN: ABSI (4.21M) vs ELDN (0).
ABSIELDNABSI / ELDN
Capitalization356M183M195%
EBITDA-83.27M-55.85M149%
Gain YTD3.053-23.544-13%
P/E RatioN/A4.81-
Revenue4.21M0-
Total Cash127M78.2M162%
Total Debt12M501K2,395%
FUNDAMENTALS RATINGS
ELDN: Fundamental Ratings
ELDN
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSIELDN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
89%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HQISX20.80N/A
N/A
Hartford Equity Income R4
GGHPX7.90N/A
N/A
Goldman Sachs Intl Eq Div & Prem P
SIEYX13.36N/A
N/A
Saratoga International Equity A
BPAVX31.49N/A
N/A
Boston Partners All Cap Value Inv
NNLEX25.81N/A
N/A
Nicholas Limited Edition N

ELDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELDN has been loosely correlated with CDXS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ELDN jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELDN
1D Price
Change %
ELDN100%
+2.94%
CDXS - ELDN
37%
Loosely correlated
-4.49%
AMLX - ELDN
37%
Loosely correlated
-1.63%
RVMD - ELDN
37%
Loosely correlated
-4.27%
PRME - ELDN
35%
Loosely correlated
-0.85%
ABSI - ELDN
34%
Loosely correlated
-3.23%
More